Save the date 03. / 04.06. 2021

BSR HIA – BALTIC SEA REGION HEALTH INNOVATION AWARD of the National Conference on Health Economy

Under the patronage of the Prime Minister of Mecklenburg-Vorpommern, Manuela Schwesig, a prize for companies - the Baltic Sea Region Innovation Award (BSR HIA) - was awarded for the first time.
The aim of the award is to improve the health care industry in the Baltic Sea region and to further promote the region. The idea is to enable the development of a product or service concept that benefits patients and attracts potential investors in and for the Baltic Sea Region. The award is endowed with 5,000 € (1st prize), 3,000 € (2nd prize) and 1,000 € (3rd prize). There is a special prize for this. This year's donors are Sparkasse Vorpommern, the Hanseatic City of Greifswald, Corak Unternehmensberatung GmbH, BioCon Valley® GmbH and WITENO GmbH. A total of 14 project applications were received, including four from Lithuania. 
The winning projects deal with the development of disinfectants against bacterial spores and the development of a plaster with integrated LED for the treatment of psoriasis. Furthermore, software solutions that use artificial intelligence to recognize the anatomical features of the heart on the basis of ultrasound images and assess its function or support the therapeutic treatment of chronic pain were also convincing.

// Prize winner 1st place  Nebula Biocides Ltd.

Project: Highly effective sporicidal disinfectant for the disinfection of hands and medical equipment

Donor of the prize: Sparkasse Vorpommern

  • Prize money in the amount of 5.000 Euro
  • additionally:
    • non-monetary, individually agreed services (e.g. consulting or coaching services, free laboratory or office space in the innovation centers) in the amount of 5,000 euros (WITENO Ltd.)
    • Travelvoucher for participation in the 17th National Conference on Health Economy at June 3 and 4, 2021 (BioCon Valley® Ltd.)

The corona pandemic has made it clear: Currently, there is no hand disinfectant that is effective against all pathogens. Although few agents can inactivate all viruses, none is effective against bacterial spores, which are now a major cause of hospital-acquired infections. That is why Nebula Biocides Ltd. has developed a revolutionary method for the disinfection of hands and medical equipment, which closes exactly this gap in effectiveness. The disinfectant can easily be produced from concentrated solutions. It is water-based, skin-friendly and non-flammable. The effective components of the disinfectant liquid produced decompose after a few minutes into harmless components and are also environmentally friendly. These properties make the new disinfectant interesting for hospitals and for hygiene in highly frequented places such as train stations, airports or shopping centers. With the pilot plant, already 18 people can disinfect their hands simultaneously. It has a modular design and works self-sufficiently except for the water supply. Thus, about one million hand disinfections can be performed with a single concentrate filling. Currently, the managing directors Schmidt-Bleker and Winter are working on the approval of the new active ingredient and hope that effective protection against infections will soon be available to everyone everywhere.

Short film about the project

// Prize winner 2nd place: EmPlastrum

Project: Patch für better treatment of psoriasis

Donor of the prize: University and Hanseatic City of Greifswald

  • Prize money in the amount of 3.000 Euro
  • in addition:
    • non-monetary, individually agreed services (e.g. consulting or coaching services, free laboratory or office space in the innovation centers) in the amount of 3,000 euros (WITENO Ltd.)
    • Travelvoucher for participation in the 17th National Conference on Health Economy at June 3 and 4, 2021 (BioCon Valley® Ltd.)

Psoriasis is a disease caused by wounds on the skin of people. Typical are sharply defined, reddened and slightly raised spots covered with silver white scales. More than 125 million people worldwide suffer from it. The Lithuanian research team "EmPlastrum" has developed a new treatment method for psoriasis. For this purpose, the founders created a flexible mobile device (plaster) of various sizes with integrated LED. The latter are active in the ultraviolet range. Psoriasis sufferers can apply these patches to their damaged skin areas. Best of all, patients remain mobile and do not need to lie down or sit still for treatment. The patch uses ultraviolet-B radiation because "this is basically the most effective light for treating Psoriasis," says founder Aurimas Mazuras. For older people, the "EmPlastrum" system is also of great advantage, "because we can transfer the treatment from medical facilities to their homes. The team is currently preparing a prototype for clinical studies. The aim is to launch "EmPlastrum" on the market in one and a half years.

Short film about the project

// Prize winner 3rd place for Ligence

Project: Deep learning algorithms for cardiac ultrasound imaging

Donor of the prize: Corak Innovation Management eG

  • Prize money in the amount of 1.000 Euro
  • additionally: 
    • non-monetary, individually agreed services (e.g. consulting or coaching services, free laboratory or office space in the innovation centers) in the amount of 1,000 euros (WITENO Ltd.)
    • Travelvoucher for participation in the 17th National Conference on Health Economy at June 3 and 4, 2021 (BioCon Valley® Ltd.)

Cardiovascular diseases together with diseases of the cardiovascular system are responsible for 37 percent of all deaths in the EU.  Cardiac ultrasound, also known as echocardiography, is routinely performed to detect such diseases."The software solution "CardioEchoAI" developed by Ligence can use artificial intelligence from ultrasound images to recognize the anatomical features of the heart and assess its function," explains Dovydas Matuliauskas, founder of the company.  It can be used as a decision support system in everyday clinical practice as well as for second opinions and big-data evaluation. Customers for the novel solution are expected to be primarily hospitals in Europe and Southeast Asia.

Short film about the project

// Special price for mAIndcraft

Project: AI-supported therapeutic software solution for the treatment of chronic pain

Donors of the prize: BioCon Valley® Ltd. and WITENO Ltd.

  • one month free use of the cowork Greifswald (WITENO Ltd.)
  • participation in thematically appropriate networking event in connection with a visit to the town hall of the Hanseatic and university city of Greifswald
  • Travelvoucher for participation in the 17th National Conference on Health Economy at June 3 and 4, 2021 (BioCon Valley® Ltd.)

mAIndcraft aims to change patients' lives and the quality of pain treatment. Based on the combination of telemedicine with advanced technology, mAindcraft enables personalized pain therapy anywhere and anytime to meet the needs of patients. The solution uses seamless analysis via continuous health monitoring to help pain therapists tailor personalized interventions to each patient in each specific situation. At the same time, it helps patients in real time to predict and apply the most appropriate coping strategy to avoid pain episodes, based on knowledge of individual pain factors and treatment progress.

Short film about the project

The HIA 2020 is organised in cooperation between BioConValley® Ltd. and WITENO Ltd. and with the support of this year's benefactors: Sparkasse Vorpommern, the Hanseatic City of Greifswald and Corak Innovation Management eG. 
We will be happy to answer further questions at hia{at}bcv.org!

benefactors

arrow_back_ios
arrow_back_ios
#Health2021